Effectiveness of the dual GIP/GLP1-agonist Tirzepatide in two cases of Alstrom syndrome, a rare obesity syndrome. Ferch M, Peitsch I, Kautzky-Willer A, Greber-Platzer S, et al. J Clin Endocrinol Metab 2025 Apr 30:dgaf258. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Ferch M, Peitsch I, Kautzky-Willer A, Greber-Platzer S, et al. Effectiveness of the dual GIP/GLP1-agonist Tirzepatide in two cases of Alstrom syndrome, a rare obesity syndrome. J Clin Endocrinol Metab 2025 Apr 30:dgaf258. doi: 10.1210.
PMID: 40302276